Case Study On Informed Consent And Patient Privacy

Although both cases and scenarios delve into informed consent and patient privacy although neither side gained any financial incentives, it still calls into question of patients rights and ethical behaviors.

Access to care could also become a challenge when genetic tests reveal hereditary conditions in the future is of major concern to patient and insurance providers. The patients concern would be access to quality healthcare without being scrutinized by the company that could result in higher premiums and deals of care.Another debate would be which patient would receive treatment when it comes to genetically engineered healthcare treatments. Although privacy laws are in place to thwart such behavior, there are no guarantees to protect consumers

from health care discrimination. Access to medical care is just one of the ethical debates that are revealed in the wake of genetic testing.

Resolutions
In a result of modern medicine making strides way to reduce the problems that have an impact on healthcare are improving methods for Access to care, Informed Consent, Right to Privacy and Nonmaleficence.

Informed consent in the area of research is an essential element of biomedical research that seeks to support the ethical value of patient and participant autonomy. Although, the approach has become incrementally complex for both researchers and participants. Obtaining consent is by no means easy: researchers must not only enlist participants in their research, however, but convey to them their rights as human subjects, the scientific question under investigation, the study methodology, and the potential damage and possible benefits. Research employ considerable effort documenting that process. Research consent categorically stresses disclosure on the presumption that additional information aids potential participants in decision-making. A solution to increase educating patient and staff on what informed consent means. Once both entities have a complete understanding, then this will allow for tests and treatments. Without any informed consent, legal and ethical issues will arise in the form of possible financial liabilities.

Access to care is an area that will become more challenging once medical scientists gain full approval on conducting treatment on our population. Although strides made are to benefit all. Unfortunately, it will come with a huge price tag. Access to care has always been a challenge for many; the disparity will increase due to cost and availability. Currently, only the wealthy can afford medical treatments that are deemed experimental, whereas the poor will have no access. Additionally, those receiving any government paid health care benefits will not be eligible either.